Suppr超能文献

肾移植和肝移植受者的膳食补充剂与草药制剂

Dietary supplements and herbal preparations in renal and liver transplant recipients.

作者信息

Foroncewicz B, Mucha K, Gryszkiewicz J, Florczak M, Mulka M, Chmura A, Szmidt J, Patkowski W, Pączek L

机构信息

Department of Immunology, Transplantology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland.

出版信息

Transplant Proc. 2011 Oct;43(8):2935-7. doi: 10.1016/j.transproceed.2011.08.008.

Abstract

BACKGROUND

Dietary supplements (DS) and herbal preparations (HP) are advertised to be safe and have therapeutic potential. They are sold over the counter. Therefore, a considerable increase in the frequency of their use has been observed; for example in the United States one in four persons taking medicines uses DS. The use of DS and HP in renal and liver transplant recipients remains unknown.

OBJECTIVES

The aim of our study was to determine the proportion of patients who used DS or HP, as well as to assess their awareness of the benefits and risks related to ingestion of these products.

METHODS

We enrolled 100 renal, liver, or combined renal and heart transplant patients into the study. They underwent a survey consisting of 14 multiple-choice questions, concerning demographic features, transplant-related data, and information about the use of DS and HP, including the frequency of use, the reasons for the purchase, the knowledge of risks and benefits, as well as the sources of information about these products.

RESULTS

Among the 58 (58%) patients who admitted their use of DS and/or HP, 20 (34.5%) ingested more than one preparation. Among liver patients, 51%, and among renal, 44%, of patients took these products for a variety of indications. Vitamins, minerals, diuretics, gastrointestinal tract-regulating, and sedative herbs were chosen most frequently. While 27% of respondents alleged to have obtained the information on DS and HP from a physician, 14% were from a pharmacist, 9% from a friend, acquaintance or neighbor, 8% from an attached leaflet, 4% from an advertisement, and 4% from the internet.

CONCLUSIONS

A high proportion of patients use DS and HP. Most preparations were taken without medical consultation. Awareness of their toxicity or drug interactions was low. Therefore, a tailored education program should be proposed for this group of patients.

摘要

背景

膳食补充剂(DS)和草药制剂(HP)宣称安全且具有治疗潜力。它们在柜台销售。因此,其使用频率显著增加;例如,在美国,每四个服药的人中就有一人使用DS。肾移植和肝移植受者中DS和HP的使用情况尚不清楚。

目的

我们研究的目的是确定使用DS或HP的患者比例,并评估他们对摄入这些产品的益处和风险的认识。

方法

我们招募了100名肾移植、肝移植或肾心联合移植患者参与研究。他们接受了一项包含14个选择题的调查,内容涉及人口统计学特征、移植相关数据以及关于DS和HP使用的信息,包括使用频率、购买原因、对风险和益处的了解以及这些产品的信息来源。

结果

在承认使用DS和/或HP的58名(58%)患者中,20名(34.5%)摄入了不止一种制剂。在肝病患者中,51%,肾病患者中44%的患者因各种适应症服用这些产品。维生素、矿物质、利尿剂、调节胃肠道的草药和镇静草药是最常选用的。虽然27%的受访者称从医生处获得了关于DS和HP的信息,14%来自药剂师,9%来自朋友、熟人或邻居,8%来自随附的说明书,4%来自广告,4%来自互联网。

结论

很大一部分患者使用DS和HP。大多数制剂是在未咨询医生的情况下服用的。对其毒性或药物相互作用的认识较低。因此,应为这组患者制定针对性的教育计划。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验